Venlafaxine Hydrochloride Tablet, Extended Release
Product Images NDC 75834-217
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 75834-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (75 mg Tablet Bottle Label)
This is a description of Venlafaxine Extended-Release tablets. The tablets come in a bottle of 1000 and each tablet contains venlafaxine hydrochloride USP equivalent to 75g in an extended-release formula. The recommended dosage is once daily, and it should be kept in a container with a child-resistant closure. The medication guide should be dispensed with each patient. It is manufactured for Nivagen Pharmaceuticals and manufactured by Gadila Pharmageutigals LTD in India. It should be stored at a temperature between 20-25°C and protected from moisture and humidity.*
Principal Display Panel (150 mg Tablet Bottle Label)
This is a bottle of Venlafaxine Extended-Release Tablets, with NDC number 75834-218-00. The bottle contains 1000 tablets which consist of Venlafane hydrochloride 150mg each, with an extended-release formulation. One medication guide is enclosed per patient. The medication is to be stored at 20-25°C (68-77°F) and protected from moisture and humidity. The usual dosage is one tablet per day, according to the prescribing information insert. The medication is to be dispensed in a safe, tight container with a child-resistant closure, and kept out of the reach of children. The product is manufactured for Nivagen Pharmaceuticals, Inc. with a toll-free number of 1-877-977-0687. The Manufacturer is Gadila Pharmageutigals Ltd. located in Dhola, Dist. Anmedabad, Gujarat Sate, INDIA. The production date of this medication is 09/2019, and it is for prescription only.*
Principal Display Panel (225 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.